Eupraxia Pharmaceuticals Inc. (EPRX) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 2 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for EPRX is $19.00, representing a +163.2% upside from the current price of $7.22. Price targets range from a low of $19.00 to a high of $19.00.
